Cost-effectiveness of transcatheter valvular interventions: Economic challenges

EuroIntervention

Volumn 9, Issue , 2013, Pages S48-S54

  Osnabrugge, Ruben L J ^a   Kappetein, A Pieter ^a   Reynolds, Matthew R ^b   Cohen, David J ^c,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost effectiveness; Economics; Transcatheter aortic valve implantation; Transcatheter mitral valve repair

Indexed keywords

AORTIC STENOSIS; AORTIC VALVE REPLACEMENT; COST EFFECTIVENESS ANALYSIS; DISEASE BURDEN; ECONOMIC ASPECT; HEALTH CARE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INTERMEDIATE RISK PATIENT; INTERMETHOD COMPARISON; LOW RISK PATIENT; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MORTALITY; QUALITY OF LIFE; REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVULAR HEART DISEASE; AORTA VALVE STENOSIS; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH; HEALTH CARE COST; HEART CATHETERIZATION; HEART SURGERY; HEART VALVE REPLACEMENT; MITRAL VALVE STENOSIS;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CARDIAC SURGICAL PROCEDURES; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MITRAL VALVE STENOSIS; WORLD HEALTH;

EID: 84903493237     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV9SSA10     Document Type: Review

References (25)

1. OECD. Health expenditure and financing: OECD Health Statistics (database). Accessed 30 May 2013.
2. Bodenheimer T. High and rising health care costs. Part 2: technologic innovation. Ann Intern Med. 2005;142:932-7.
3. Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ. 2012;345:e4710.
4. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-11.
5. Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, Lereun CM, Bogers AJ, Piazza N, Kappetein AP. Aortic Stenosis in the Elderly: Disease Prevalence and Number of Candidates for Transcatheter Aortic Valve Replacement: A meta-analysis and modelling study. J Am Coll Cardiol. 2013 May 29. [Epub ahead of print]
6. Clark MA, Duhay FG, Thompson AK, Keyes MJ, Svensson LG, Bonow RO, Stockwell BT, Cohen DJ. Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients. Risk Manag Healthc Policy. 2012;5:117-26.
7. Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak J, Kodali SK, Lasala JM, O'Neill WW, Davidson CJ, Smith CR, Leon MB, Cohen DJ; PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012;125:1102-9.
8. Reynolds MR, Magnuson EA, Lei Y, Wang K, Vilain K, Li H, Walczak J, Pinto DS, Thourani VH, Svensson LG, Mack MJ, Miller DC, Satler LE, Bavaria J, Smith CR, Leon MB, Cohen DJ; PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012;60:2683-92.
9. Mylotte D, Osnabrugge RL, Windecker S, Lefevre T, de Jaegere P, Jeger R, Wenaweser P, Maisano F, Moat N, Sondergaard L, Bosmans J, Teles RC, Martucci G, Manoharan G, Garcia E, Van Mieghem NM, Kappetein AP, Serruys PW, Lange R, Piazza N. Transcatheter Aortic Valve Replacement in Europe: Adoption Trends and Factors Influencing Device Utilization. J Am Coll Cardiol. 2013 May 15. [Epub ahead of print]
10. Doble B, Blackhouse G, Goeree R, Xie F. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective. J Thorac Cardiovasc Surg. 2012 Jul 11. [Epub ahead of print].
11. Gada H, Agarwal S, Marwick TH. Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: Outcomes of a decision-analytic model. Ann Cardiothorac Surg. 2012;1:145-55.
12. Gada H, Kapadia SR, Tuzcu EM, Svensson LG, Marwick TH. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol. 2012;109:1326-33.
13. Hancock-Howard RL, Feindel CM, Rodes-Cabau J, Webb JG, Thompson AK, Banz K. Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings. J Med Econ. 2013;16:566-74.
14. Watt M, Mealing S, Eaton J, Piazza N, Moat N, Brasseur P, Palmer S, Busca R, Sculpher M. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart. 2012;98:370-6.
15. Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open. 2012;2.
16. World Health Organization. CHOosing Interventions that are Cost Effective (WHO-CHOICE). http://www.who.int/choice/costs/CER-thresholds/en/. Accessed: 31 May 2013.
17. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-95.
18. Reynolds MR, Magnuson EA, Wang K, Thourani VH, Williams M, Zajarias A, Rihal CS, Brown DL, Smith CR, Leon MB, Cohen DJ; PARTNER Trial Investigators. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol. 2012;60:548-58.
19. Osnabrugge RL, Head SJ, Genders TS, Van Mieghem NM, De Jaegere PP, van der Boon RM, Kerkvliet JM, Kalesan B, Bogers AJ, Kappetein AP, Hunink MG. Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Ann Thorac Surg. 2012;94:1954-60.
20. Fairbairn TA, Meads DM, Hulme C, Mather AN, Plein S, Blackman DJ, Greenwood JP. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart. 2013;99:914-20.
21. Osnabrugge RL, Speir AM, Head SJ, Fonner CE, Fonner E, Ailawadi G, Kappetein AP, Rich JB. Costs for surgical aortic valve replacement according to preoperative risk categories. Ann Thorac Surg. 2013 Jun 16. [Epub ahead of print].
22. Osnabrugge RL, Head SJ, Bogers AJ, Kappetein P. Patient selection for transcatheter aortic valve replacement: what does the future hold? Expert Rev Cardiovasc Ther. 2012;10:679-81.
23. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395-406.
24. Mauri L, Foster E, Glower DD, Apruzzese P, Massaro JM, Herrmann HC, Hermiller J, Gray W, Wang A, Pedersen WR, Bajwa T, Lasala J, Low R, Grayburn P, Feldman T. Four-year Results of a Randomized Controlled Trial of Percutaneous Repair Versus Surgery for Mitral Regurgitation. J Am Coll Cardiol. 2013 May 8. [Epub ahead of print]
25. Reynolds M, Galper B, Apruzzese P, Walczak J, Mauri L, Feldman T, Glower D, Cohen D. TCT-786 abstract Cost Effectiveness of the MitraClip® Compared with Mitral Valve Surgery: 12-month Results from the EVEREST II Randomized Controlled Trial. J Am Coll Cardiol. 2012;60.